or
forgot password

    • cancer clinical trials in la jolla, CA

    • Everolimus Plus Best Supportive Care vs Placebo Plus Best Supportive Care in the Treatment of Patients With Advanced Neuroendocrine Tumors (GI or Lung Origin)
    Scripps Clinic Regulatory

    Trial Locations
    Scripps Clinic Regulatory
    University of California San Diego Regulatory
    Advanced NET of GI Origin, Advanced NET of Lung Origin, Neuroendocrine Tumors
    A Randomized, Double-Blind and Placebo-Controlled Study of Idelalisib in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)
    University of California, San Diego- Moores Cancer Center
    La Jolla, California 92093
    Chronic Lymphocytic Leukemia
    Veliparib in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
    Moores University of California San Diego Cancer Center
    LA Jolla, California 92093
    BRCA1 Mutation Carrier, BRCA2 Mutation Carrier, Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer, Recurrent Primary Peritoneal Cavity Cancer
    Study With Intensity Modulated Radiation Therapy With Cisplatin to Treat Stage I-IVA Cervical Cancer
    Moores UC San Diego Cancer Center
    La Jolla, California 92093
    Cervical Cancer
    Intensity Modulated Radiation Therapy With Cisplatin and Gemcitabine to Treat Locally Advanced Cervical Carcinoma
    Moores UC San Diego Cancer Center
    La Jolla, California 92093
    Cervical Carcinoma
    Open-label Extension Study of Navitoclax in Subjects With Chronic Lymphocytic Leukemia (CLL)
    Site Reference ID/Investigator# 74036
    La Jolla, California 92093
    Chronic Lymphocytic Leukemia
    Phase 1/2, Open-label, Dose-escalation Study of ISIS-STAT3Rx, Administered to Patients With Advanced Cancers
    Moores UC San Diego Cancer Center
    La Jolla, California 92093
    Advanced Cancers, DLBCL, Lymphoma
    Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer Who Have No Evidence of Disease After Surgery
    Moores University of California San Diego Cancer Center
    LA Jolla, California 92093
    Clear Cell Renal Cell Carcinoma, Stage IV Renal Cell Cancer
    Safety Study of Attenuated Vaccinia Virus (GL-ONC1)With Combination Therapy in Head & Neck Cancer
    Moores UC San Diego Cancer Center
    La Jolla, California 92093
    Cancer of Head and Neck
    Revlimid® as Consolidation Treatment Chronic Lymphocytic Leukemia
    Moores UCSD Cancer Center
    La Jolla, California 92093-0658
    Chronic Lymphocytic Leukemia
    Cardiovascular Outcomes Study of Naltrexone SR/Bupropion SR in Overweight and Obese Subjects With Cardiovascular Risk Factors (The Light Study)
    Obesity Research Network Scripps Clinic

    Trial Locations
    Obesity Research Network Scripps Clinic
    XiMED Center for Weight Management
    Obesity, Overweight
    Ovarian Cancer Vaccine for Patients Who Have Progressed During the CAN-003 Study
    Scripps Cancer Center
    La Jolla, California 92037
    Epithelial Ovarian Cancer
    Clinical Study of WT2725 in Patients With Advanced Solid Malignancies
    UC San Diego Moores Cancer Center
    La Jolla, California 92093
    Cancer
    Dexanabinol in Patients With Brain Cancer
    Moores UCSD Cancer Center
    La Jolla, California 92093-0658
    Brain Cancer
    Study of BMS-936558 vs. Everolimus in Pre-Treated Advanced Or Metastatic Clear-cell RCC
    UCSD Moores Cancer Center
    La Jolla, California 93093
    Advanced or Metastatic (Medically or Surgically Unresectable) Clear-cell Renal Cell Carcinoma
    A Phase 1b Study Evaluating the Safety and Tolerability of ABT-199 in Combination With Rituximab in Subjects With Relapsed Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
    Site Reference ID/Investigator# 70398
    La Jolla, California 92093-0698
    Small Lymphocytic Lymphoma, Chronic Lymphocytic Leukemia
    HD IL-2 + Vemurafenib in Patients With BRAF Mutation Positive Metastatic Melanoma
    Moores UCSD Cancer Center
    La Jolla, California 92093-0658
    Metastatic Melanoma
    A Study of HSP90 Inhibitor AT13387 Alone or in Combination With Abiraterone Acetate
    Moores UCSD Cancer Center
    La Jolla, California 92093-0658
    Prostate Cancer
    Phase 3b Safety and Efficacy Study of Apremilast to Treat Moderate to Severe Plaque-plaque Psoriasis
    University of California, San Diego
    La Jolla, California 92037-1709
    Psoriasis, Psoriatic Arthritis
    TRYHARD: Radiation Therapy Plus Cisplatin With or Without Lapatinib in Treating Patients With Head and Neck Cancer.
    University of California, San Diego
    La Jolla, California 92037-1709
    Non-HPV Locally Advanced Head and Neck Cancer
    Scripps Tumorgraft Study
    Scripps Translational Science Institute
    La Jolla, California 92037
    Solid Tumor Malignancy or Hematologic Malignancy
    Safety Study of CC-292 and Rituximab in Subjects With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
    UCSD Moores Cancer Center
    La Jolla, California 93093
    Leukemia Lymphocytic Chronic B-Cell
    Post-approval Study of NovoTTF-100A in Recurrent GBM Patients
    University of California San Diego Moores Cancer Center
    La Jolla, California
    Recurrent Glioblastoma Multiforme
    A Study Using MABp1 To Increase Overall Survival In Patients With Colorectal Cancer And Weight Loss
    Moores UCSD Cancer Center
    La Jolla, California 92093-0658
    Metastatic Colorectal Cancer, Cachexia, Weight Loss
    OTIS Autoimmune Diseases in Pregnancy Project
    University of California, San Diego
    La Jolla, California 92037-1709
    Crohn's Disease, Rheumatoid Arthritis
    Circulating Tumor Cells in Non-Small Cell Lung Carcinoma
    Moores Cancer Center
    La Jolla, California 92093-0820
    Primary Lung Cancer
    Pasos Hacia La Salud - Physical Activity Intervention for Latinas
    University of California San Diego
    La Jolla, California 92093
    Inactivity
    Using Technology to Improve Physical Activity Levels Among Postmenopausal Women (The Active & Aware Study)
    Moores UCSD Cancer Center
    La Jolla, California 92093-0658
    Breast Cancer
    Validation of Objective Measures of Place-Based Physical Activity
    University of California, San Diego
    La Jolla, California 92037-1709
    Physical Activity
    PACE CALL: Weight Loss Study for Childhood Leukemia Survivors
    UC San Diego
    La Jolla, California 92093
    Acute Lymphoblastic Leukemia, Cancer, Obesity
    Wellderly Immune Antibodies Study, a Sub-Study of Healthy Elderly Active Longevity (HEAL) Cohort
    Scripps Translational Science Institute
    La Jolla, California 92037
    Antibodies Involved in Healthy Aging
    Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic Leukemia
    University of California San Diego Cancer Center
    La Jolla, California 92093-0658
    Leukemia, Lymphoma
    Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer
    University of California San Diego Cancer Center
    La Jolla, California 92093-0658
    Lung Cancer
    Vinorelbine Plus Cisplatin or No Further Therapy in Treating Patients With Non-small Cell Lung Cancer That Has Been Surgically Removed
    University of California San Diego Cancer Center
    La Jolla, California 92093-0658
    Lung Cancer
    Combination Chemotherapy Followed by Bone Marrow and/or Peripheral Stem Cell Transplantation in Treating Patients With Recurrent Medulloblastoma or CNS Germ Cell Tumors
    Rebecca and John Moores UCSD Cancer Center
    La Jolla, California 92093-0658
    Brain and Central Nervous System Tumors
    Combination Chemotherapy With or Without Bone Marrow or Stem Cell Transplantation in Treating Men With Untreated Germ Cell Tumors
    Rebecca and John Moores UCSD Cancer Center
    La Jolla, California 92093-0658
    Childhood Germ Cell Tumor, Extragonadal Germ Cell Tumor, Testicular Germ Cell Tumor
    Radiation Therapy With or Without Antiandrogen Therapy in Treating Patients With Stage I or Stage II Prostate Cancer
    University of California San Diego Cancer Center
    La Jolla, California 92093-0658
    Prostate Cancer
    Chemotherapy With or Without Surgery, Radiation Therapy, or Stem Cell Transplantation in Treating Young Patients With Kidney Tumors
    Rebecca and John Moores UCSD Cancer Center
    La Jolla, California 92093-0658
    Kidney Cancer
    Combination Chemotherapy Alone or With Radiation Therapy in Treating Children With Kidney Cancer
    Rebecca and John Moores UCSD Cancer Center
    La Jolla, California 92093-0658
    Kidney Cancer
    Paclitaxel or Docetaxel in Treating Women With Advanced Breast Cancer
    Green Cancer Center at Scripps Clinic
    La Jolla, California 92037
    Breast Cancer
    Radiation Therapy and Chemotherapy in Treating Children With CNS Relapse From Acute Lymphoblastic Leukemia
    University of California San Diego Cancer Center
    La Jolla, California 92093-0658
    Leukemia
    Topotecan in Treating Children With Refractory Leukemia
    University of California San Diego Cancer Center
    La Jolla, California 92093-0658
    Leukemia
    Radiation Therapy With or Without Radiosurgery in Treating Patients With Brain Metastases
    University of California San Diego Cancer Center
    La Jolla, California 92093-0658
    Metastatic Cancer
    Correlation of Menstrual Cycle Phase at Time of Primary Surgery With 5-Year Disease-Free Survival in Women With Stage I or Stage II Breast Cancer
    Rebecca and John Moores UCSD Cancer Center

    Trial Locations
    Rebecca and John Moores UCSD Cancer Center
    Scripps Cancer Center at Scripps Clinic
    Breast Cancer, Perioperative/Postoperative Complications
    Combination Chemotherapy With or Without PSC 833 in Treating Patients With Relapsed or Refractory Multiple Myeloma
    University of California San Diego Cancer Center
    La Jolla, California 92093-0658
    Multiple Myeloma and Plasma Cell Neoplasm
    Marimastat in Treating Patients With Stage III Non-Small Cell Lung Cancer
    Scripps Clinic

    Trial Locations
    Scripps Clinic
    Scripps Memorial Hospital Stevens Cancer Center
    Lung Cancer
    Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy
    University of California San Diego Cancer Center
    La Jolla, California 92093-0658
    Prostate Cancer
    Combination Chemotherapy Plus PSC 833 Followed by Interleukin-2 in Treating Patients With Acute Myelogenous Leukemia
    University of California San Diego Cancer Center
    La Jolla, California 92093-0658
    Leukemia
    Octreotide, Tamoxifen, and Chemotherapy in Treating Women With Breast Cancer
    University of California San Diego Cancer Center
    La Jolla, California 92093-0658
    Breast Cancer